» Articles » PMID: 16516461

Surgeons' Views on Multi-disciplinary Breast Meetings

Overview
Journal Eur J Cancer
Specialty Oncology
Date 2006 Mar 7
PMID 16516461
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to assess surgeons' views and their current commitments to multi-disciplinary breast meetings (MDMs). Two hundred and fifty questionnaires were sent out to registered members of the British Association of Surgical Oncology. Hundred and fifty-three were returned (reply rate 61.2%), of which 136 were suitable for analysis. All those who replied were involved in MDMs. 80.9% held MDMs once a week. Only 28% of MDMs were held during a protected session. Over 95% of surgeons and breast care nurses were present for the whole meeting. Radiologists and pathologists were present for the whole meeting in 90-95% of cases. In contrast, clinical oncologists were present for the whole MDM in 70% of cases and medical oncologists attended the whole meeting in only 44.1% of cases. There was variability in which patients were discussed in MDMs, and in many centres not all patients with cancer were discussed before surgery. Suggestions for improvement of MDMs included more time on protected sessions (72.8% in favour), time to prepare for meetings (29% in favour), allocation of a designated co-ordinator (30.9% in favour) and attendance of oncologists for the whole meeting (over 35% in favour). The majority of Breast MDMs were held at breakfast, lunch or the evening. There was variable attendance with a significant percentage of both clinical and medical oncologists not being present for the whole meeting. A quarter of units did not discuss patients with breast cancer before operation. This study shows that there is a need to improve provision for MDMs and to produce guidelines for these meetings.

Citing Articles

Factors influencing the quality and functioning of oncological multidisciplinary team meetings: results of a systematic review.

Walraven J, van der Hel O, van der Hoeven J, Lemmens V, Verhoeven R, Desar I BMC Health Serv Res. 2022; 22(1):829.

PMID: 35761282 PMC: 9238082. DOI: 10.1186/s12913-022-08112-0.


Patient Participation in Multidisciplinary Tumor Conferences from the Providers' Perspective: Is It Feasible in Routine Cancer Care?.

Heuser C, Diekmann A, Schellenberger B, Bohmeier B, Kuhn W, Karbach U J Multidiscip Healthc. 2020; 13:1729-1739.

PMID: 33273821 PMC: 7708776. DOI: 10.2147/JMDH.S283166.


Improving outcomes in lung cancer: the value of the multidisciplinary health care team.

Denton E, Conron M J Multidiscip Healthc. 2016; 9:137-44.

PMID: 27099511 PMC: 4820200. DOI: 10.2147/JMDH.S76762.


Multidisciplinary breast cancer teams and proposed standards.

Guler S, Canturk N Ulus Cerrahi Derg. 2015; 31(1):39-41.

PMID: 25931943 PMC: 4415545. DOI: 10.5152/UCD.2014.2724.


What is the role of the multidisciplinary team in the management of urinary incontinence?.

Balachandran A, Duckett J Int Urogynecol J. 2014; 26(6):791-3.

PMID: 25416023 DOI: 10.1007/s00192-014-2579-3.